New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis

gan Etxeberria, Iñaki, Glez-Vaz, Javier, Teijeira, Álvaro, Melero, Ignacio
Cyhoeddwyd yn ESMO Open (2020)

Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms

gan Etxeberria, Iñaki, Olivera, Irene, Bolaños, Elixabet, Cirella, Asunta, Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
Cyhoeddwyd yn Cell Mol Immunol (2020)

Cellular immunotherapies for cancer

gan Berraondo, Pedro, Labiano, Sara, Minute, Luna, Etxeberria, Iñaki, Vasquez, Marcos, Sanchez-Arraez, Alvaro, Teijeira, Alvaro, Melero, Ignacio
Cyhoeddwyd yn Oncoimmunology (2017)

Cytokines in clinical cancer immunotherapy

gan Berraondo, Pedro, Sanmamed, Miguel F., Ochoa, María C, Etxeberria, Iñaki, Aznar, Maria A., Pérez-Gracia, José Luis, Rodríguez-Ruiz, María E., Ponz-Sarvise, Mariano, Castañón, Eduardo, Melero, Ignacio
Cyhoeddwyd yn Br J Cancer (2018)

Human CD8 T cells are susceptible to TNF-mediated activation-induced cell death

gan Otano, Itziar, Alvarez, Maite, Minute, Luna, Ochoa, María Carmen, Migueliz, Itziar, Molina, Carmen, Azpilikueta, Arantza, de Andrea, Carlos E., Etxeberria, Iñaki, Sanmamed, Miguel F., Teijeira, Álvaro, Berraondo, Pedro, Melero, Ignacio
Cyhoeddwyd yn Theranostics (2020)

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15

gan Ochoa, Maria Carmen, Minute, Luna, López, Ascensión, Pérez-Ruiz, Elisabeth, Gomar, Celia, Vasquez, Marcos, Inoges, Susana, Etxeberria, Iñaki, Rodriguez, Inmaculada, Garasa, Saray, Mayer, Jan-Peter Andreas, Wirtz, Peter, Melero, Ignacio, Berraondo, Pedro
Cyhoeddwyd yn Oncoimmunology (2017)

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

gan Azpilikueta, Arantza, Bolaños, Elixabet, Lang, Valerie, Labiano, Sara, Aznar, Maria A., Etxeberria, Iñaki, Teijeira, Alvaro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Jure-Kunkel, Maria, Zapata, Juan M., Rodriguez, Manuel S., Melero, Ignacio
Cyhoeddwyd yn Oncoimmunology (2017)

Repurposing the yellow fever vaccine for intratumoral immunotherapy

gan Aznar, Maria Angela, Molina, Carmen, Teijeira, Alvaro, Rodriguez, Inmaculada, Azpilikueta, Arantza, Garasa, Saray, Sanchez‐Paulete, Alfonso R, Cordeiro, Luna, Etxeberria, Iñaki, Alvarez, Maite, Rius‐Rocabert, Sergio, Nistal‐Villan, Estanislao, Berraondo, Pedro, Melero, Ignacio
Cyhoeddwyd yn EMBO Mol Med (2019)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

gan Aznar, M. Angela, Planelles, Lourdes, Perez-Olivares, Mercedes, Molina, Carmen, Garasa, Saray, Etxeberría, Iñaki, Perez, Guiomar, Rodriguez, Inmaculada, Bolaños, Elixabet, Lopez-Casas, Pedro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Marquez-Rodas, Ivan, Teijeira, Alvaro, Quintero, Marisol, Melero, Ignacio
Cyhoeddwyd yn J Immunother Cancer (2019)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

gan Labiano, Sara, Meléndez-Rodríguez, Florinda, Palazón, Asís, Teijeira, Álvaro, Garasa, Saray, Etxeberria, Iñaki, Aznar, M. Ángela, Sánchez-Paulete, Alfonso R., Azpilikueta, Arantza, Bolaños, Elixabet, Molina, Carmen, de la Fuente, Hortensia, Maiso, Patricia, Sánchez-Madrid, Francisco, de Landázuri, Manuel Ortiz, Aragonés, Julián, Melero, Ignacio
Cyhoeddwyd yn Oncoimmunology (2017)

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

gan Etxeberria, Iñaki, Bolaños, Elixabet, Teijeira, Alvaro, Garasa, Saray, Yanguas, Alba, Azpilikueta, Arantza, Kavanaugh, William M., Vasiljeva, Olga, Belvin, Marcia, Howng, Bruce, Irving, Bryan, Tipton, Kimberly, West, James, Mei, Li, Korman, Alan J., Sega, Emanuela, Olivera, Irene, Cirella, Assunta, Ochoa, Maria C., Rodriguez, Maria E., Melero, Ana, Sanmamed, Miguel F., Engelhardt, John J., Melero, Ignacio
Cyhoeddwyd yn Proc Natl Acad Sci U S A (2021)